Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Chronic Kidney Diseases

1,25-dihydroxyergocalciferol has been researched along with Chronic Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Boer, IH; Denburg, MR; Foerster, D; Kalkwarf, HJ; Leonard, MB; Shults, J; Stokes, D; Tsampalieros, AK; Zemel, BS1
Kimber, C; Mahnken, JD; Stubbs, JR; Wetmore, JB1

Trials

1 trial(s) available for 1,25-dihydroxyergocalciferol and Chronic Kidney Diseases

ArticleYear
Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    The British journal of nutrition, 2016, Volume: 116, Issue:12

    Topics: 25-Hydroxyvitamin D 2; Academic Medical Centers; Adult; Aged; Calcifediol; Calcitriol; Cholecalciferol; Cohort Studies; Dietary Supplements; Double-Blind Method; Ergocalciferols; Female; Follow-Up Studies; Humans; Kansas; Male; Middle Aged; Outpatient Clinics, Hospital; Parathyroid Hormone; Renal Insufficiency, Chronic; Reproducibility of Results; Vitamin D Deficiency

2016

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Chronic Kidney Diseases

ArticleYear
Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:5

    Topics: Adolescent; Adolescent Development; Adult; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Calcitriol; Child; Child Development; Child, Preschool; Cohort Studies; Ergocalciferols; Fractures, Bone; Humans; Hypocalcemia; Parathyroid Hormone; Prospective Studies; Renal Insufficiency, Chronic; Risk; United States; Young Adult

2013